Perhaps most promisingly, emerging biomarkers-particularly interleukin-6, interleukin-10, and procalcitonin-have substantially enhanced our ability to stratify infection risk, demonstrating sensitivity exceeding 85% for bacteraemia detection. Here, IL10 is linked to infection.